Strategic Medical Associates (SMA) seeks to elevate the American population’s knowledge of drugs, biologics, medical devices, and vaccines as well as knowledge of their development processes. It is through these efforts we help improve patient representation in clinical trials that better align with the burden of diseases or conditions the products are designed to treat.
Low clinical trial participation is often linked to mistrust and limited access to clear information. We believe trust in clinical trials and disease treatments—and, in turn, stronger participation—can best be achieved by sharing unbiased information about their development processes and how stakeholders can help shape them.
Patients prefer to receive information about clinical trials from a trusted physician. SMA deploys programs to assist every physician-caregiver, health professional, and health institution with their understanding of the therapeutic innovation processes that allows them to contribute to better disease treatments, and better care to the patients who trust them.
We seek to enhance the knowledge, influence, and involvement of trusted health care providers by better informing them of treatment innovations and clinical trials strategies that are relevant to the needs and preferences of their patients. By empowering physicians in multiple roles, we improve community engagement in clinical trials, ensuring that all patient groups are adequately represented, and their diverse health needs are effectively addressed.
SMA is dedicated to offering patients information they can use from people they can trust in language they can understand!
